Global Continuous Glucose Monitoring (CGM) Market Research Report 2023

Publication ID:

PB504236576

Publication Date:

April 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Highlights
The global Continuous Glucose Monitoring (CGM) market was valued at US$ 4612 million in 2022 and is anticipated to reach US$ 5979.4 million by 2029, witnessing a CAGR of 3.7% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM).
The Continuous Glucose Monitoring (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Continuous Glucose Monitoring (CGM) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Continuous Glucose Monitoring (CGM) Market Overview
1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM)
1.2 Continuous Glucose Monitoring (CGM) Segment by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2023-2029)
1.2.2 Transmitters
1.2.3 Sensors
1.2.4 Insulin Pumps
1.3 Continuous Glucose Monitoring (CGM) Segment by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Global Continuous Glucose Monitoring (CGM) Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) Revenue 2018-2029
1.4.2 Global Continuous Glucose Monitoring (CGM) Sales 2018-2029
1.4.3 Global Continuous Glucose Monitoring (CGM) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturers (2018-2023)
2.4 Global Continuous Glucose Monitoring (CGM) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
2.7 Continuous Glucose Monitoring (CGM) Market Competitive Situation and Trends
2.7.1 Continuous Glucose Monitoring (CGM) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) Players Market Share by Revenue
2.7.3 Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuous Glucose Monitoring (CGM) Retrospective Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Continuous Glucose Monitoring (CGM) Global Continuous Glucose Monitoring (CGM) Sales by Region: 2018-2029
3.2.1 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2018-2023
3.2.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2024-2029
3.3 Global Continuous Glucose Monitoring (CGM) Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2018-2029
3.3.1 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2018-2023
3.3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2024-2029
3.4 North America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Continuous Glucose Monitoring (CGM) Sales by Country (2018-2029)
3.4.3 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2018-2029)
3.5.3 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Country (2018-2029)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2018-2029)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2018-2029)
4.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2018-2023)
4.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Type (2024-2029)
4.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2018-2029)
4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2018-2029)
4.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2018-2023)
4.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2024-2029)
4.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2018-2029)
4.3 Global Continuous Glucose Monitoring (CGM) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2018-2029)
5.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2018-2023)
5.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Application (2024-2029)
5.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2018-2029)
5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2018-2029)
5.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2018-2023)
5.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2024-2029)
5.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2018-2029)
5.3 Global Continuous Glucose Monitoring (CGM) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Continuous Glucose Monitoring (CGM) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Animas
6.5.1 Animas Corporation Information
6.5.2 Animas Description and Business Overview
6.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Animas Continuous Glucose Monitoring (CGM) Product Portfolio
6.5.5 Animas Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 GlySens
6.8.1 GlySens Corporation Information
6.8.2 GlySens Description and Business Overview
6.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GlySens Continuous Glucose Monitoring (CGM) Product Portfolio
6.8.5 GlySens Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) Production Mode & Process
7.4 Continuous Glucose Monitoring (CGM) Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) Distributors
7.5 Continuous Glucose Monitoring (CGM) Customers
8 Continuous Glucose Monitoring (CGM) Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) Industry Trends
8.2 Continuous Glucose Monitoring (CGM) Market Drivers
8.3 Continuous Glucose Monitoring (CGM) Market Challenges
8.4 Continuous Glucose Monitoring (CGM) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂